Annals ofRheumatoid Arthritis

Volume: 1 - Number: 6 - December 15, 2003

Outstanding

The yin and yang of rheumatoid arthritis

Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis despite Stable Doses of Methotrexate: A Randomized, Double-Blind, Placebo-Controlled Trial

Growing Pains: The ILAR Classification of Juvenile Idiopathic Arthritis

Efficacy and safety of the fully human anti-tumour necrosis factor monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Antiphospholipids Syndrome

Human Immunodeficiency Virus Infection, Antiphospholipid Antibodies, and the Antiphospholipid Syndrome

Arthritis and hypertension

Hypertension in the Patient with Arthritis: Have We Been Underestimating Its Significance?

Cytokines

IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis

IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis

IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-B

Early arthritis. Abstracts

Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis of the hands, after application of a structured management protocol

Editorial

Gender Differences in Access and Use of Health Care Services

Generalist, Specialist, or Both?

Globalization of Rheumatology: Activities of ILAR. Think Global -- Act Local

Evidence

How Do I Know Thee . . . Let Me Count the Ways. The Varieties of Medical Evidence

Gene Therapy

Gene therapy for rheumatoid arthritis?

Gota

Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter

Gout, Diet, and the Insulin Resistance Syndrome

Juvenile Idiopathic Arthritis

Growing Pains: The ILAR Classification of Juvenile Idiopathic Arthritis

Osteology

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

Pharmacology

Genetic and pharmacological analysis of prostanoid receptor function

Proteoglycans

Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena

Psoriatics arthritis

Genetic Studies of PsA: Dissecting Joints and Skin

HLA Studies in Psoriatic Arthritis: Current Situation and Future Needs

Rheumatoid Arthritis

Genetic Control of T Cell Receptor BJ Gene Expression in Peripheral Lymphocytes of Normal and Rheumatoid Arthritis Monozygotic Twins

HLA-DQB1 Polymorphism Determines Incidence, Onset, and Severity of Collagen-induced Arthritis in Transgenic Mice . Implications in Human Rheumatoid Arthritis

The yin and yang of rheumatoid arthritis

Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis despite Stable Doses of Methotrexate: A Randomized, Double-Blind, Placebo-Controlled Trial

Rheumatoid Arthritis—A Molecular Understanding

Are Long-Term Very Low Doses of Prednisone for Patients with Rheumatoid Arthritis as Helpful as High Doses Are Harmful?

Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Rheumatoid arthritis. Abstracts

Estimation of inflammation by Doppler ultrasound: quantitative changes after intra-articular treatment in rheumatoid arthritis

Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis

Genetic Bias in Immune Responses to a Cassette Shared by Different Microorganisms in Patients with Rheumatoid Arthritis

Rheumatology

Psychosocial Factors in Diffuse Upper Limb Disorder

Progress in the treatment of rheumatic disease

Scleroderma

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients

Therapeutic: Abstracts

Association between etanercept use and employment outcomes among patients with rheumatoid arthritis

Tumor necrosis factor-alpha , its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: Implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloid

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

Efficacy and safety of the fully human anti-tumour necrosis factor monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor blockers can make sense

Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis

Effect of tumour necrosis factor antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection

Therapeutics

Balancing Bones and Bucks Among New Glucocorticoid Users

Therapy

Retinoids and Rexinoids for the 21st Century: A Brave New World for Arthritis